Higher expression and peptide binding affinity of HLA‐E*01:03 were also proposed to be the cause of a reduced probability of relapse, due to the increased efficiency of peptide presentation to CD8+ T cells inducing a stronger graft‐versus‐leukaemia (GvL) effect [90, 98]. The gene discussed is HLA-E; the disease is leukemia.